The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery
Prada‐Villaverde A, Esquivel J, Lowy A, Markman M, Chua T, Pelz J, Baratti D, Baumgartner J, Berri R, Bretcha‐Boix P, Deraco M, Flores‐Ayala G, Glehen O, Gomez‐Portilla A, González‐Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spiliotis J, Torres‐Melero J, Turaga K, Trout R. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery. Journal Of Surgical Oncology 2014, 110: 779-785. PMID: 25088304, DOI: 10.1002/jso.23728.Peer-Reviewed Original ResearchMeSH KeywordsAntibiotics, AntineoplasticAntineoplastic AgentsChemotherapy, Cancer, Regional PerfusionColorectal NeoplasmsCombined Modality TherapyDigestive System Surgical ProceduresFemaleFollow-Up StudiesHumansHyperthermia, InducedInjections, IntraperitonealMaleMiddle AgedMitomycinNeoplasm StagingOrganoplatinum CompoundsOxaliplatinPeritoneal NeoplasmsPrognosisRetrospective StudiesSurvival RateConceptsPeritoneal Surface Disease Severity ScoreHyperthermic intraperitoneal chemotherapyAmerican Society of Peritoneal Surface MalignanciesOverall survivalMitomycin CCytoreductive surgeryOS ratesMedian overall survivalPeritoneal surface malignanciesMitomycin C groupDisease severity scoresAmerican SocietyComplete cytoreductionPeritoneal carcinomatosisIntraperitoneal chemotherapySurface malignanciesOxaliplatin groupIII/IV patientsProspective studyOxaliplatinColon cancerColorectal cancerCytoreductionSeverity scorePatientsThe American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis
Esquivel J, Lowy A, Markman M, Chua T, Pelz J, Baratti D, Baumgartner J, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spilioitis J, Torres-Melero J, Turaga K, Trout R. The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis. Annals Of Surgical Oncology 2014, 21: 4195-4201. PMID: 24854493, DOI: 10.1245/s10434-014-3798-z.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, Cancer, Regional PerfusionColorectal NeoplasmsCombined Modality TherapyCytoreduction Surgical ProceduresFemaleFollow-Up StudiesHumansHyperthermia, InducedLymphatic MetastasisMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingPeritoneal NeoplasmsPrognosisRetrospective StudiesSeverity of Illness IndexSurvival RateYoung AdultConceptsPeritoneal Surface Disease Severity ScoreAmerican Society of Peritoneal Surface MalignanciesHyperthermic intraperitoneal chemotherapyPeritoneal surface malignanciesDisease severity scoresPeritoneal carcinomatosisSurface malignanciesMedian survivalClinical trialsSeverity scoreManagement of colorectal cancer patientsImprove patient selectionLikelihood of long-term survivalColorectal cancer patientsLong-term survivalStandard of careCytoreductive surgeryIntraperitoneal chemotherapyOverall survivalRetrospective reviewPatient selectionColorectal cancerCancer patientsCRS/HIPECConclusionsThese data
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply